DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 6,177,074
|Title:||Polyethylene glycol modified interferon therapy|
|Abstract:||A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.|
|Inventor(s):||Glue; Paul (Flemington, NJ), Cutler; David L. (Morristown, NJ), Affrime; Melton B. (Flemington, NJ)|
|Assignee:||Schering Corporation (Kenilworth, NJ)|
1. A method for treating a patient suspected of having hepatitis C infection, comprising administering to the patient, in combination, (i) a conjugate comprising PEG.sub.12000
and interferon alpha-2b in an amount of from 0.5 .mu.g/kg to 2.0 .mu.g/kg, once or twice per week in single or divided doses, and (ii) ribavirin.
2. The method of claim 1 wherein the conjugate is administered in an amount of 0.5 .mu.g/kg twice per week.
3. The method of claim 1 wherein the conjugate is administered in an amount of 2.0 .mu.g/kg once per week.
4. The method of claim 1 wherein the conjugate is administered in an amount of 0.5, 1.0 or 1.5 .mu.g/kg once per week.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.